60 Degrees Pharmaceuticals Files Updated Investor Presentation

What Happened

• 60 Degrees Pharmaceuticals, Inc. (SXTP) filed a Current Report on Form 8-K on July 20, 2026, under Item 7.01 (Regulation FD Disclosure) to furnish an updated investor presentation.
• The slide deck is provided as Exhibit 99.1 to the 8-K and is incorporated by reference; the filing does not announce earnings, executive changes, or other material corporate actions.

Key Details

• Filing date: July 20, 2026.
• Item reported: 7.01 Regulation FD Disclosure; exhibit furnished as Exhibit 99.1.
• Purpose: updated investor presentation intended for use with investors, analysts and the investment community.
• No financial results or management changes were reported in this filing.

Why It Matters

• The update signals the company has refreshed the materials it uses to communicate strategy, pipeline or progress to investors; the actual content and any operational or financial updates are in the furnished presentation (Exhibit 99.1).
• Retail investors should review the attached investor presentation on the SEC EDGAR site or the company website to see if there are substantive updates relevant to investment decisions.